Detection the Serogroups of Escherichia coli isolates from Urine sample of UTI patients

Authors

  • Fakhri S.Ahmed Ph.D

DOI:

https://doi.org/10.37506/ijfmt.v15i1.13557

Keywords:

Biofilm, E. coli, UTIs, Resistance of antibiotics, uro-pathogenic Escherichia coli.

Abstract

Aims: Determining of E.coli serogroups which isolation from UTI patients
Patients and Methods: the study was conducted between September 2019 to April 2020 and they was
collected 40 sample from patient how are diagnosis with UTI during this study .
Results: From the UTI patients individuals, 40 strains were identified in which O serogroups showed
8(30%) and 2 (20%), respectively, of occurrence in those strains. Moreover, the enterohemorrhagic E. coli
(O157 H7) and the enteroaggregative E. coli (O44 H7) were detected in two strains of the UTI-based urine
samples only. For the antibiotic resistance properties of the biofilm positive producers isolated from the UTI
urine samples, multidrug resistance was revealed in 60% of those isolates; however, only 20% of the biofilm
negative producers from the UTI urine samples showed the MDR characteristics. Biofilm was identified in
75% of the UTI urine. For the antibiotic sensitivity test, the results demonstrated that the sensitivity rates to
Imipenem, Amikaci, gentamicin, and tobramycin were 90%, 100%, 65%, and 40%, respectively, in the UTI
strains.
Conclusion: The herein study provides thorough data about the Escherichia coli based biofilm,

Author Biography

Fakhri S.Ahmed Ph.D

Lecture in Department of medical laboratory technology, Al-Hikma University college

Published

2020-12-31

How to Cite

Fakhri S.Ahmed Ph.D. (2020). Detection the Serogroups of Escherichia coli isolates from Urine sample of UTI patients. Indian Journal of Forensic Medicine & Toxicology, 15(1), 1068-1071. https://doi.org/10.37506/ijfmt.v15i1.13557

Issue

Vol. 15 No. 1 (2021): Indian Journal of Forensic Medicine & Toxicology

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details

https://creativecommons.org/licenses/

CC BY

This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.

  1. The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
  1. The journal allows the author(s) to hold the copyright without restrictions.
  1. The journal allows the author(s) to retain publishing rights without restrictions